The concentration of high-sensitivity troponin I, galectin-3 and NT-proBNP substantially increase after a 60-km ultramarathon

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 2, 2014, Pages 267-272

  Salvagno, Gian Luca ^a   Schena, Federico ^b   Gelati, Matteo ^a   Danese, Elisa ^a   Cervellin, Gianfranco ^c   Guidi, Gian Cesare ^a   Lippi, Giuseppe ^d  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c ACADEMIC HOSPITAL OF PARMA   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

Cardiac injury; Galectin 3; Nt probnp; Sports; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GALECTIN 3; HIGH SENSITIVITY TROPONIN I; TROPONIN I; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ENDURANCE TRAINING; HUMAN; HUMAN EXPERIMENT; MARATHON RUNNER; MIDDLE AGED; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RUNNING; ULTRAMARATHON;

ADULT; BIOLOGICAL MARKERS; GALECTIN 3; HEART INJURIES; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RUNNING; TROPONIN I;

EID: 84896292888     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0601     Document Type: Article

References (28)

1. Lippi G, Plebani M. Biomarker research and leading causes of death worldwide: a rather feeble relationship. Clin Chem Lab Med 2013;51:1691-3
2. van Kimmenade RR, Januzzi JL Jr. Emerging biomarkers in heart failure. Clin Chem 2012;58:127-38
3. Lackner KJ. Laboratory diagnostics of myocardial infarction - troponins and beyond. Clin Chem Lab Med 2013;51:83-9
4. Lippi G, Franchini M, Cervellin G. Diagnosis and management of ischemic heart disease. Semin Thromb Hemost 2013;39:202-13
5. Lippi G, Montagnana M, Aloe R, Cervellin G. Highly sensitive troponin immunoassays: navigating between the Scylla and Charybdis. Adv Clin Chem 2012;58:1-29
6. Yancy CW, Jessup M, Bozkurt B, Masoudi FA, Butler J, McBride PE, et al. ACCF/AHA Task Force members. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2013. Available from doi:10.1016/j.jacc.2013.05.019. First published online: 5 June 2013 [Epub ahead of print]
7. Mastandrea P. The diagnostic utility of brain natriuretic peptide in heart failure patients presenting with acute dyspnea: a meta-analysis. Clin Chem Lab Med 2013;51:1155-65
8. Cheng JM, Akkerhuis KM, Battes LC, van Vark LC, Hillege HL, Paulus WJ, et al. Biomarkers of heart failure with normal ejection fraction: a systematic review. Eur J Heart Fail 2013. Available from doi: 10.1093/eurjhf/hft106. First published online: 11 July 2013 [Epub ahead of print]
9. Chen K, Jiang RJ, Wang CQ, Yin ZF, Fan YQ, Cao JT, et al. Predictive value of plasma galectin-3 in patients with chronic heart failure. Eur Rev Med Pharmacol Sci 2013;17:1005-11
10. Gaggin HK, Januzzi JL Jr. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta 2013. Available from doi: 10.1016/j.bbadis.2012.12.014. First published online: 9 Jan 2013 [Epub ahead of print]
11. Lippi G, Banfi G, Botrè F, de la Torre X, De Vita F, Gomez-Cabrera MC, et al. Laboratory medicine and sports: between Scylla and Charybdis. Clin Chem Lab Med 2012;50:1309-16
12. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009;55:573-7
13. Lippi G, Margapoti R, Aloe R, Cervellin G. Highly-sensitive troponin I in patients admitted to the emergency room with acute infections. Eur J Intern Med 2013;24:e57-8
14. Prontera C, Zucchelli GC, Vittorini S, Storti S, Emdin M, Clerico A. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP. Clin Chim Acta 2009;400:70-3
15. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Committee for practice guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-69
16. van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian A, et al. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail 2013;6:219-26
17. Di Somma S, Navarin S, Giordano S, Spadini F, Lippi G, Cervellin G, et al. The emerging role of biomarkers and bio-impedance in evaluating hydration status in patients with acute heart failure. Clin Chem Lab Med 2012;50:2093-105
18. Lippi G, Cavazza M, Peracino A, Tubaro M, Nechita A, Ballarino P, et al. Ischemic heart disease in the emergency room: state of the art, innovation and research. Emerg Care J 2013;9:e7. Available from doi: 10.4081/ecj.2013.e7 [Epub ahead of print]
19. Lippi G, Cervellin G, Banfi G, Plebani M. Cardiac troponins and physical exercise. It's time to make a point. Biochem Med (Zagreb) 2011;21:55-62
20. Lippi G, Banfi G. Exercise-related increase of cardiac troponin release in sports: an apparent paradox finally elucidated? Clin Chim Acta 2010;411:610-1
21. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012;172:1211-8
22. Lippi G, Schena F, Salvagno GL, Montagnana M, Gelati M, Tarperi C, et al. Influence of a half-marathon run on NT-proBNP and troponin T. Clin Lab 2008;54:251-4
23. de Boer RA, Yu L, van Veldhuisen DJ. Galectin-3 in cardiac remodeling and heart failure. Curr Heart Fail Rep 2010;7:1-8
24. Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 2004;110:3121-8
25. Liu YH, D'Ambrosio M, Liao TD, Peng H, Rhaleb NE, Sharma U, et al. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin. Am J Physiol Heart Circ Physiol 2009;296:H404-12
26. de Boer RA, Edelmann F, Cohen-Solal A, Mamas MA, Maisel A, Pieske B. Galectin-3 in heart failure with preserved ejection fraction. Eur J Heart Fail 2013. Available from doi: 10.1093/ eurjhf/hft077. First published online: 5 May 2013 [Epub ahead of print]
27. de Boer RA, Lok DJ, Jaarsma T, van der Meer P, Voors AA, Hillege HL, et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 2011;43:60-8
28. Wilson M, O'Hanlon R, Basavarajaiah S, George K, Green D, Ainslie P, et al. Cardiovascular function and the veteran athlete. Eur J Appl Physiol 2010;110:459-78.